Omics Sciences for the Identification of Pathogenetic Mechanisms and Biomarkers in Neurodegenerative Diseases
Recruiting · NCT07235111 · Observational (researchers observe without assigning treatment) · Lead sponsor: Ospedale Policlinico San Martino
View the official record on ClinicalTrials.gov →What this trial is about
The study aims to use 'omics' sciences, employing the most advanced technologies currently available, in order to identify pathogenic genomic variants, proteins and/or altered molecular pathways in neurodegenerative diseases and to obtain a new and more complete characterisation of subjects affected by the neurodegenerative diseases under study. Thanks to the integration of genomic, gene expression (transcriptomic and epigenomic), protein and metabolic data and clinical data, the study also aims to identify new markers for the diagnosis, prognosis, also in terms of response to therapy, and monitoring of neurodegenerative diseases. The study involves the enrolment of at least 1.200 individuals with neurodegenerative disease.
Who can take part
Inclusion criteria
- Patients suffering from neurodegenerative diseases
Exclusion criteria
- Patients not suffering from neurodegenerative diseases
Where it is running
1 location listed.
- Ospedale Policlinico San Martino - Genoa, Genoa, Italy